Through research and scientific exchange, we guarantee that our patients have access to state-of-the-art therapeutic options. The main research topic of our division is somatic disorders and neuroinflammation in mental illness. Basic research and longitudinal research should increase the basic understanding of mechanisms and processes of mental illnesses while clinical trials should lead to new diagnosis and treatment options. This will guarantee that our patients receive the best possible clinical care. Patients have the opportunity to participate in clinical trials and thus have the privilege of taking new medications.

Head of Division

Eva Maria Reininghaus 
T: +43 316 385 13612

Scientific Director

Nina Dalkner  
T: +43 316 385 30081

Holistic health as the goal of research

In addition to clinical patient care and education, another very important focus of our division is science and research.

Our main research areas investigate the course and neurobiological background of bipolar affective disorder and severe psychiatric conditions, cognitive sciences, nutritional psychiatry, psychiatric genetics, imaging and EEG, psychocardiology and biopsychosocial models in psychiatry, psychpharmacology and psychotherapy and intervention research.


BIPFAT/BIPLONG: Connection between bipolar disorder (BIP) and metabolic factors (FAT) in the long term (LONG)

Clinical trials: Effectiveness and Tolerance of Psychotropic Drugs and Psychotherapeutic Methods

  • Randomized controlled trials to investigate the effectiveness and effects of psychopharmacological treatment (e.g., S-ketamine) and psychotherapy (e.g., Cognitive Behavioral Analysis System of Psychotherapy) or psychoeducation for severe mental illness
  • Project partners: Uni Graz, Department of Psychology, City of Graz, JANSSEN

Mental disorders and somatic disease – psychohepatology, psychocardiology and psychodermatology

Psychological effects of COVID-19

Lifestyle, gut health and neurobiological fundamentals in mental illness